Pretreatment Primary Tumor Stage is a Risk Factor for Recurrence in Patients with Esophageal Squamous Cell Carcinoma Who Achieve Pathological Complete Response After Neoadjuvant Chemoradiotherapy

BACKGROUND: Although pathological complete response (pCR) after multimodal treatment for esophageal cancer is associated to the best prognosis, recurrence may occur in 20–40% of cases. The present study investigated the recurrence pattern and predictive factors of recurrence after pCR in patients wi...

Descripción completa

Detalles Bibliográficos
Autores principales: La Mendola, Roberta, Bencivenga, Maria, Torroni, Lorena, Alberti, Luca, Sacco, Michele, Casella, Francesco, Ridolfi, Cecilia, Simoni, Nicola, Micera, Renato, Pavarana, Michele, Verlato, Giuseppe, Giacopuzzi, Simone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Thoracic Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119402/
https://www.ncbi.nlm.nih.gov/pubmed/33078313
http://dx.doi.org/10.1245/s10434-020-09219-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119402/
https://www.ncbi.nlm.nih.gov/pubmed/33078313
http://dx.doi.org/10.1245/s10434-020-09219-6

Ejemplares similares